Introduction: Molecular targeting drugs are recommended as second-line treatment for
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …

The aim of the present study was to predict the effects of transarterial infusion (TAI)
chemotherapy based on early changes in α‑fetoprotein (AFP) and des‑γ‑carboxy …

Abstract Background and Aim: The clinical utility of alpha‐fetoprotein (AFP) and des‐γ‐
carboxy prothrombin (DCP) as a predictor of treatment outcome in patients with advanced …

Background & Aims Hepatic arterial infusion chemotherapy (HAIC) is an option for treating
advanced hepatocellular carcinoma (HCC). Because of the poor prognosis in HAIC non …

Aim Hepatic arterial infusion chemotherapy (HAIC) is a potent therapeutic option for
advanced hepatocellular carcinoma (HCC). However, there are few known predictive factors …

Abstract Background and Aim To assess the early response and outcome of hepatic arterial
infusion chemotherapy (HAIC) in patients with advanced hepatocellular carcinoma (HCC) …

PURPOSE: Serial α-fetoprotein (AFP) measurements are useful for assessing tumor
responses to numerous therapies for hepatocellular carcinoma (HCC). This study tested the …

Abstract Background/Aims Alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin
(DCP) have been used as diagnostic tools for hepatocellular carcinoma (HCC). However …

Objective We retrospectively investigated the relationship between the tumor response and
serial changes in α-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP) during hepatic …

Background The prognosis of patients with advanced hepatocellular carcinoma (HCC) is
poor. We aimed to clarify the prognostic factors in patients with advanced HCC receiving …